Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$78M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| -48.4% |
| Open the original filing on SEC.gov |
| Oct 14 | CRSP | CRISPR Therapeutics AG | MEXER◷ | 30,000 | $14.00 | $420K | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV◆ | 198,019 | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV◆ | 2M | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV◆ | 1.8M | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV◆ | 600,962 | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV◆ | 1.3M | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV◆ | 3.9M | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | PBUY | 592,593 | $17.00 | $10.1M | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV | 169,001 | — | — | +10.1% | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV | 1.7M | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | PBUY | 414,814 | $17.00 | $7.1M | +27.0% | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV | 1.5M | — | — | — | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | PBUY | 592,593 | $17.00 | $10.1M | +11.9% | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV | 512,897 | — | — | +11.5% | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV | 1.1M | — | — | +33.4% | Open the original filing on SEC.gov |
| Sep 28 | ADRX | ADARx Pharmaceuticals,… | CCONV | 3.3M | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | NKTX | Nkarta, Inc. | AGRANT◆ | 37,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | DSGN | Design Therapeutics, Inc. | AGRANT◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 16, 2025 | CRSP | CRISPR Therapeutics AG | PBUY | 960,983 | $52.03 | $50M | +124.9% | Open the original filing on SEC.gov |
| Jul 16, 2025 | CRSP | CRISPR Therapeutics AG | PBUY | 22,319 | $52.03 | $1.2M | +10.3% | Open the original filing on SEC.gov |
| Jul 16, 2025 | CRSP | CRISPR Therapeutics AG | PBUY | 6,510 | $52.03 | $338.7K | +10.3% | Open the original filing on SEC.gov |
| Jun 10, 2025 | DSGN | Design Therapeutics, Inc. | AGRANT◆ | 19,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | CRSP | CRISPR Therapeutics AG | AGRANT◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | NKTX | Nkarta, Inc. | AGRANT◆ | 46,000 | — | — | — | Open the original filing on SEC.gov |